Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases

Clinical trial NCT06078813 · RECRUITING

Trial details

NCT number: NCT06078813
Sponsor: Cancer Trials Ireland
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Spine Metastases

Start date: 2023-11-21
Primary completion: 2028-08-31
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.